(Q67247455)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

0 references

1 reference

E G Chadwick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

R Yogev

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

S T Shulman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

R E Weinfeld

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

I H Patel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

language of work or name

English

0 references

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

11 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

134-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins

11 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Pharmacokinetics and Bacteriologic Efficacy of Moxalactam, Cefotaxime, Cefoperazone, and Rocephin in Experimental Bacterial Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Single-dose pharmacokinetics of ceftriaxone in infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Pharmacokinetics of ceftriaxone in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Description and classification of the newer cephalosporins and their relationships with the established compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980311-4

10.1016/S0022-3476(83)80311-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6294263%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference